This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meng, L. Articles by Bulun, S. E. Search for Related Content PubMed PubMed Citation Articles by Meng, L. Articles by Bulun, S. E.

Tumor Necrosis Factor and Interleukin 11 Secreted by Malignant Breast Epithelial Cells Inhibit Adipocyte Differentiation by Selectively Down-Regulating CCAAT/Enhancer Binding Protein and Peroxisome Proliferator-activated Receptor

Mechanism of Desmoplastic Reaction¹

Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235 [L. M., K. M. Z.]; Departments of Obstetrics and Gynecology and Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois 60612-7313 [J. Z., S. E. B.]; and Department of Pathology, Tohoku University School of Medicine, Sendai 980, Japan [H. S., T. S.]

	ABSTRACT

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
The dense layer of fibroblasts that accumulate around malignant breast epithelial cells (i.e., desmoplastic reaction) arises from the breast adipose tissue and provides structural and biochemical support for breast cancer. We report herein a number of epithelial-stromal interactions responsible for desmoplastic reaction in breast cancer using cultured 3T3-L1 murine fibroblasts and human adipose fibroblasts, which can be activated with a mixture of hormones to differentiate to mature adipocytes. Adipocyte differentiation was inhibited by coculturing fibroblasts with various breast cancer cell lines (T47D, MCF-7, SSC202, SSC78, and SSC30) completely or by breast cancer cell conditioned media in a dose-dependent manner; on the other hand, adipocyte differentiation was not inhibited by coculturing with normal human primary mammary epithelial cell conditioned medium. This tumor effect was eliminated using neutralizing antibodies against tumor necrosis factor (TNF)- or interleukin (IL)-11. TNF- and IL-11 levels were 2.5–3 times higher in T47D conditioned medium compared with control medium, and TNF- transcripts were detectable in T47D but not in 3T3-L1 cells in culture, indicating that the malignant epithelial cell is the major site of cytokine production. This was confirmed in vivo in mastectomy specimens, where immunoreactive TNF- and IL-11 were readily detectable in malignant epithelial cells but not in the majority of the surrounding fibroblasts. Adipocyte differentiation is mediated by the expression of a cascade of adipogenic transcription factors, including CCAAT/enhancer binding protein (C/EBP)ß, C/EBP, peroxisome proliferator-activated receptor (PPAR) and C/EBP. C/EBP and PPAR are essential for this process. We demonstrated by Northern analysis that exposure of activated 3T3-L1 cells to T47D cell conditioned medium strikingly decreased the levels of PPAR and C/EBP transcripts and increased the levels of C/EBPß and C/EBP transcripts. In these 3T3-L1 cells, inhibition of differentiation was also confirmed by markedly suppressed levels of aP2 mRNA, which is an adipocyte-specific gene. These in vitro observations were confirmed in sections of human malignant breast tumors, where immunoreactive C/EBP was readily detectable in adipose fibroblasts distant to the tumor but not in intratumoral fibroblasts. Treatment of 3T3-L1 cells with T47D cell conditioned medium or TNF- changed neither the numbers of cells in G₀-G₁, S, and G₂ phases nor the rate of [³H]thymidine incorporation, thus ruling out a proliferative effect of malignant cells on the surrounding fibroblasts. In summary, desmoplastic reaction primarily occurs via the action of cytokines (TNF- and IL-11) secreted by the malignant epithelial cells to inhibit differentiation of adipose fibroblasts to mature adipocytes. This tumor-induced block in adipocyte differentiation is mediated by the selective inhibition of expression of the essential adipogenic transcription factors, i.e., PPAR and C/EBP.

	INTRODUCTION

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Breast tumors are characterized by the accumulation of fibroblasts adjacent to malignant epithelial cells, which is commonly known as the desmoplastic reaction (1) . In fact, the majority of breast cancers have been referred to as "scirrhous" because of their extremely hard consistency provided by large numbers of fibroblasts dispersed between malignant epithelial cells, as well as within the immediate periphery of tumors. The relationship between adipose stroma and breast cancer is unique in the sense that stromal fibroblasts seem to provide the structural support for cancer growth, whereas malignant cells greatly influence the composition of the adjacent tissue. Evidence from several laboratories indicates that this epithelial-stromal interaction also involves paracrine mechanisms that promote the development and growth of breast carcinomas (2, 3, 4) . These morphologically identified intra- and peritumoral fibroblasts originate from adipose tissue and most likely represent potential preadipocytes, because fibroblasts isolated from adipose tissue are capable of differentiating to mature adipocytes under defined culture conditions (5 , 6) . We hypothesized that malignant epithelial cells of breast tumors secrete growth factors and cytokines to prevent the differentiation of fibroblasts to mature adipocytes in the adjacent adipose tissue. The following body of preliminary data supported this hypothesis:

(a) Tumors were found in breast quadrants with the highest P450arom⁴ transcript levels and the highest fibroblast:adipocyte ratio (7) . This parallelism between the distribution of fibroblasts and aromatase expression is not surprising, because aromatase is a marker for undifferentiated adipose fibroblasts (8 , 9) .

(b) In the cancer-free human breast, the highest fibroblast:adipocyte ratios and P450arom transcript levels were found in the lateral and upper region (10) . This distribution roughly correlates with the most common sites where infiltrating duct carcinomas develop.

(c) Breast tumor conditioned medium was found to induce aromatase activity in adipose fibroblasts (11) . This tumor-induced effect can be inhibited and titrated by addition of an anti-IL-11 antibody.⁵ When aromatase expression is viewed as a fibroblast marker, these results suggested that malignant epithelial cells secrete factors, such as IL-11, to prevent differentiation of fibroblasts. Additionally, estradiol pretreatment of cancer cells potentiated aromatase induction in a dose-dependent fashion, which is suggestive of a paracrine loop (11) . Moreover, we demonstrated that certain adipogenesis inhibitors such as IL-11 are secreted by the T47D breast cancer cell line (12) . Again, estradiol stimulated IL-11 expression in T47D cells in a dose-dependent fashion (12) .

(d) IL-11 and TNF stimulation of the fibroblast marker aromatase in adipose fibroblasts can be interpreted as inhibition of adipocyte differentiation, because aromatase expression in adipose tissue primarily resides in fibroblasts but not in mature adipocytes (8 , 9 , 13 , 14) .

There may be multiple potential mechanisms responsible for accumulation of adipose fibroblasts within the tumor and in adjacent stroma. It is possible that fibroblasts proliferate in response to tumor-derived growth factors. Although treatment of murine 3T3-L1 fibroblasts in culture with serum, insulin, insulin-like growth factor I and epidermal growth factor initially causes proliferation, cell replication rapidly stops under these conditions, and fibroblasts eventually differentiate into mature adipocytes (15, 16, 17, 18) . Thus, it follows that there have to be other effective mechanisms for peritumoral fibroblast accumulation. Inhibition of differentiation or dedifferentiation of preexisting adipocytes may provide these critical mechanisms responsible for extremely high fibroblast:adipocyte ratios in the stroma surrounding cancer cells. This process may be under the control of cytokines secreted by the malignant epithelial cells.

The cellular and molecular mechanisms responsible for the differentiation of stromal fibroblasts into mature adipocytes have been well characterized (19, 20, 21, 22, 23, 24) . During mammalian development, embryonic mesoderm gives rise to several highly specialized cell types, including adipocytes. Differentiation of adipocytes from multipotential fibroblastic precursors is primarily controlled by two tissue-specific transcription factors: the C/EBP and PPAR. During the process of differentiation, C/EBPß (and possibly C/EBP) are initially expressed and convert multipotential mesenchymal precursor cells into preadipocytes (19) . These "determined" preadipocytes are able to respond subsequently to potent adipogenic inducers such as PPAR. The PPAR isoform PPAR (21) is a member of the ligand-activated transcription factor family that heterodimerizes with retinoid X receptor and binds to the promoters of adipocyte-specific genes. A third adipocyte-enriched transcription factor, C/EBP, has been shown to promote terminal adipocyte differentiation (20) . When expressed together, PPAR and C/EBP act synergistically to powerfully promote adipocyte differentiation in fibroblastic cells, regardless of tissue of origin (22 , 24) . For practical purposes, we will refer to undifferentiated mesenchymal precursors and determined preadipocytes in human adipose tissue as adipose fibroblasts, because both cell types appear as fibroblasts morphologically. Fibroblasts isolated from adipose tissue differentiate into adipocytes when cultured in a defined medium (5 , 6) . On the other hand, certain substances, such as TNF-, are not only capable of inhibiting adipocyte differentiation but also of reversing it by suppressing the expression of PPAR (25 , 26) . Most of the work in this field has been performed using rodent fibroblasts and has been related to obesity and diabetes. Possible roles of malignant epithelial cells in paracrine regulation of these transcription factors and on adipocyte differentiation have not been studied to date. We report herein a number of epithelial-stromal interactions in the breast cancer, which represent cellular and molecular mechanisms responsible for the development and maintenance of desmoplastic reaction.

	MATERIALS AND METHODS

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Tissue Acquisition.
Breast adipose tissue was obtained from five patients undergoing reduction mammoplasty. These tissues were immediately processed for primary cultures of adipose fibroblasts. Breast cancer and surrounding adipose tissue samples were obtained from 25 mastectomy specimens for immunohistological detection of C/EBPs (, ß, and ), IL-11, and TNF-. These studies were conducted following protocols approved by the Institutional Review Boards of the University of Texas Southwestern Medical Center and Tohoku University School of Medicine.

Detection of Transcripts of Adipocyte-specific Genes and Cytokines by RNA Blot Analysis.
Total RNA was isolated from fibroblasts/adipocytes in culture, electrophoretically fractionated (10 µg), and transferred to a charged membrane. Duplicate measurements of absorbance (260 µm) were performed to equalize loading, which was confirmed by visual inspection of 18S and 28S RNA stained with ethidium bromide. Northern blots were hybridized with cDNA probes labeled by random priming using [³²P]dCTP. cDNA templates for adipocyte P2 (aP2), C/EBP, C/EBPß, PPAR, C/EBP, and TNF- were kindly provided by Drs. Steve McKnight, Gokhan Hotamisligil, Carol Mendelson, Bruce Beutler, and Gretchen Darlington.

Cell Cultures and Differentiation of Fibroblasts to Adipocytes.
We routinely performed primary cultures of human adipose fibroblasts as described previously (8) . Differentiation of human adipose fibroblasts to mature adipocytes was performed following a modified protocol originally outlined by Hauner et al. (5) . Breast adipose tissue, obtained from women at the time of reduction mammoplasty, was processed by mincing, washing, digestion (with collagenase), and centrifugation steps. The floating mature adipocytes were aspirated, and the sedimented fibroblast fraction was resuspended in DMEM with 10% FCS as described previously (8) . Nucleus-containing cells were inoculated at a density of 50,000/cm² into six-well plates. Cultures were grown for a 24-h period in DMEM with 10% FCS. Cells were then placed in a chemically defined phenol red-free and serum-free medium consisting of DMEM/F12 (1:1, v/v), 15 mM NaHCO₃, 15 mM HEPES, 33 µM biotin, 17 µM pantothenate, 0.67 µM human insulin, 0.2 mM triiodothyronine, 0.5 mM DEX, and antibiotics for 21 days. Within 15–21 days, cells achieve maximum differentiation. Cells were regarded as differentiated by morphological criteria when, after acquiring a round shape, the cytoplasm was completely filled with multiple lipid droplets as assessed by Oil Red O staining. The proportion of differentiated cells is estimated by direct counting under the microscope of total and differentiated cells, using a micrometer.

The 3T3-L1 fibroblasts were grown in DMEM with 10% FCS. T47D cells were initially grown in RPMI 1640 with 10% FCS containing 0.02 mM HEPES, whereas MCF-7 cells were grown in MEM with 10% FCS until confluent. SSC202, SC78, and SSC30 breast cancer cells (kindly provided by Dr. Adi Gazdar) were grown to confluence in DMEM with 10% FCS. Primary human mammary epithelial cells purchased from Clonetics, Inc. (Walkersville, MD) were grown to confluence in the MEGM medium supplied by the manufacturer (Clonetics). Cell conditioned medium from T47D and human mammary epithelial cells were collected for coculture experiments in the following fashion. Confluent cells were maintained in DMEM for 12 h for washout. Then, cells were incubated in DMEM for 24 h to allow accumulation of factors secreted by these cells. These conditioned media were subsequently used for coculture experiments. All cells were incubated at 37°C in 5% CO₂. To induce the adipogenic differentiation of 3T3-L1 fibroblasts within 2 days of reaching confluence, these cells were treated with DEX (0.25 µm), MIX (0.5 mM), and insulin (1 µg/ml) for 2 days and then maintained in DMEM with 10% FCS for 6 additional days. Cells containing multiple fat droplets were scored as differentiated by phase contrast microscope after staining with Oil Red O. All culture media were phenol red free.

Neutralizing antibodies against human IL-11 (Ab-218-NA), TNF- (Ab-210-NA), IL-2, and normal goat IgG (AB-108-C) were purchased from R&D Systems, Inc. (Minneapolis, MN). These were added to the conditioned medium at a final concentration of 40 ng/ml.

As an alternative to the use of breast cancer cell conditioned media, 3T3-L1 and human adipose fibroblasts were cocultured with breast cancer cells using 35-mm, six-well plates. 3T3-L1 cells or adipose fibroblasts were plated on the bottom wells. Breast cancer cells were seeded on the permeable membrane (0.45-µm) tissue culture inserts. 3T3-L1 cells were cultured in DMEM with 10% FCS, after they reached confluence for 2 days. At this time, inserts containing cancer cells were introduced, and the medium was changed to the appropriate differentiation medium for 48 h. Then the medium was switched back to DMEM plus 10% FCS for 6 days. In the case of human adipose fibroblasts, cocultures were maintained for 15–20 days in the differentiating medium, because human cells required prolonged exposure to this medium in contrast to 3T3-L1 murine fibroblasts. At the end of coculture experiments, human adipose fibroblasts or 3T3-L1 cells in the bottom plate were evaluated for differentiation to mature adipocytes and for proliferative indices (rate of [³H]thymidine incorporation and flow cytometry) or were harvested for RNA isolation.

Immunohistochemistry.
Antihuman IL-II, TNF-, C/EBP, C/EBPß, and C/EBP antibodies were purchased from R&D Systems, Inc. The immunohistochemical procedures were performed, as described previously, on 2.5-µm-thick sections mounted on poly-L-lysine-coated slides using the biotin-streptavidin amplified technique with a histone immunostaining kit (Nichirei, Tokyo, Japan). Briefly, this staining procedure was performed as follows: (a) routine deparaffinization; (b) inactivation of endogenous peroxidase activity with 0.3% H₂O₂ in methanol for 20 min at 23°C; (c) blocking with 1% goat serum for 45 min at 23°C; (d) incubation with the primary antibody at 4°C for 18 h; (e) incubation with biotinylated goat antirabbit antibody for 30 min at 23°C; (f) incubation with peroxidase-conjugated streptavidin for 30 min at 23°C; (g) colorimetric reaction with a solution containing 0.05% Tris-HCl (pH 7.6), 0.66 M 3,3'-diaminobenzidine, and 2 M H₂O₂; and (h) counterstaining with 1% methyl green.

ELISA Assay.
For the determination of IL-11 and TNF- concentrations in breast cancer cell conditioned media, IL-11 and TNF- ELISA immunoassay kits (R&D Systems, Inc.) were used according to the instructions supplemented by the vendor. Briefly, samples of media were collected immediately before and 2 days after the addition of these media to 3T3-L1 cells. Samples (100 µl) were assayed in triplicate. After 2–16 h of incubation at room temperature, each well was aspirated. IL-11 or TNF- conjugates (200 µl) were added to the wells and incubated for 2 h at room temperature. Each well was aspirated. The substrate solution (200 µl) was then added to each well and incubated for 30 min. After adding 50 µl of the stop solution to each well, the absorbance was immediately determined at a wavelength of 450 nm. IL-11 or TNF- concentrations were calculated by creating standard curves and plotting the mean absorbance for each standard on the Y axis against the concentration on the X axis.

	RESULTS

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Effects of Tumor Cells on the Differentiation of Fibroblasts to Adipocytes.
Confluent 3T3-L1 cells differentiate to mature adipocytes within 4 or 6 days after a 48-h treatment with a mixture including insulin, DEX, and MIX. At this stage, the cells appear rounded and possess numerous large cytosolic lipid spheres, as revealed by Oil Red O staining (Fig. 1A1) . The effect of the T47D breast cancer cell line on the adipogenic differentiation of the 3T3-L1 cells was evaluated with cocultures or T47D cell conditioned medium. Medium conditioned with T47D breast cancer cells completely inhibited the differentiation of 3T3-L1 cells (Fig. 1A2) . Upon addition of neutralizing antibodies to human IL-11 and TNF-, this effect was totally reversed. In other words, neutralizing both of these cytokines reversed the inhibitory effect of breast cancer cells on adipocyte differentiation (Fig. 1A3) . This reversal was partial when either antibody was used separately and was dose dependent (data not shown). Antihuman IL-2 neutralizing antibodies or the normal goat IgG antibody did not reverse the inhibition, indicating that the effects of anti-IL-11 and TNF- neutralizing antibodies were specific.

View larger version (68K): [in this window] [in a new window]   Fig. 1. 3T3-L1 cells, 8 days after reaching confluence. Confluent cells were treated with the differentiating cocktail (DEX, insulin, and MIX) for the first 2 days and then were maintained in DMEM for the next 6 days. Accumulation of lipid droplets represented by the red stain was detected in the cytoplasm of 80% of adipocytes (A1; stain, Oil Red O). Adding medium conditioned with breast cancer cells (in this instance, T47D cells) completely inhibited their differentiation to adipocytes, evident by the lack of lipid droplets (A2). After neutralizing antibodies against IL-11 and TNF- at the final concentrations of 40 µg/ml were added to the conditioned media, this cancer-induced inhibition of differentiation was totally reversed (A3). This indicates that cancer cells inhibit adipocyte differentiation, at least in part, by the secretion of IL-11 and TNF-. B, levels of TNF- (B1) and IL-11 (B2) in various conditioned media before (Day 0) and after (Day 2) addition to 3T3-L1 cells in culture. DMEM, Control medium; COC, differentiating cocktail. Bars, SE. C, Northern blot analysis demonstrating TNF- transcripts in T47D breast cancer cells treated with lipopolysaccharide (LPS, 1 µg/ml) and TNF- (10 ng/ml) for 3 h. Under similar treatment conditions, transcripts were not detected in 3T3-L1 murine fibroblasts. The murine RAW264.7 macrophage line was used as a positive control, whereas the U937 human leukemia cell line was used as a negative control. The probe was a full-length murine TNF- cDNA (the molecular weight of human transcripts was relatively lower, as expected). D, immunoreactive TNF- (D1) and IL-11 (D2) were readily detectable in malignant epithelial cells but not in fibroblasts. The Brown stain indicates immunoreactive cytokines (arrows). These representative sections depict similar data observed in breast cancer samples from 15 patients.

Cellular Localization of the Cytokines Inhibitory for Adipocyte Differentiation in the Breast Cancer.
Previous experiments have suggested that IL-11and TNF- mediated the inhibition of adipocyte differentiation by cancer cells. Thus, we determined the cellular origin of these cytokines in breast cancer:

(a) Both TNF- and IL-11 concentrations in TCM were 2.5–3 times those found in media conditioned with control cells. The levels of these cytokines did not increase during the incubation of 3T3-L1 cells, indicating that 60–75% of IL-11 and TNF- in the medium arises from T47D cells (Fig. 1, B1 and B2) .

(b) We demonstrated TNF- transcripts in T47D breast cells but not in 3T3-L1 cells, using Northern blotting (Fig. 1C) .

(c) We determined the in vivo cellular distribution of immunoreactive IL-11 and TNF- in 15 mastectomy specimens. These two cytokines were primarily expressed in all malignant epithelial cells. Less than 25% of fibroblasts contained immunoreactive IL-11 or TNF- with considerably less staining intensity (Fig. 1D) .

Expression of PPAR, C/EBP, and aP2 in 3T3-L1 Cells Cocultured with Breast Cancer Cells.
We determined the levels of transcripts of C/EBP, C/EBPß, C/EPB, PPAR, and aP2 by Northern analysis in cocktail-treated 3T3-L1 cells exposed to conditioned media from T47D breast cancer cells (TCM) and HEMC normal breast epithelial cells (NCM). Fig. 2 depicts these results. Treatment with TCM strikingly decreased the transcript levels of C/EBP and PPAR in 3T3-L1 cells, whereas it significantly potentiated the effects of the differentiation mixture to induce the expression of C/EBPß and C/EBP during days 4 and 6 after the initiation of treatment. As expected, TCM also inhibited the expression of aP2, which is a marker for adipocyte differentiation (Fig. 2B) . Upon the addition of a neutralizing antibody against TNF-, the effects of TCM on C/EBPs and PPAR expression were reversed completely (Fig. 2C) , whereas NCM did not change the expression pattern of C/EBPs and PPAR. This demonstrated that the inhibition caused by TCM on the induction of C/EBP and PPAR was specific for malignant epithelial cells. These results were further confirmed by performing human breast tumor immunohistochemistry.

View larger version (46K): [in this window] [in a new window]   Fig. 2. Northern blot showing the levels of transcripts of C/EBP, C/EBPß, C/EBP (A), PPAR, and aP2 (B) in 10 µg of total RNA from 3T3-L1 cells incubated under conditions explained in the legend of Fig. 1B . The 28S RNA fraction was included to demonstrate the presence of comparable amounts of RNA in each lane. DMEM, control medium; COC, differentiating cocktail. T47D cells (TCM) inhibited expression of C/EBP and PPAR and enhanced expression C/EBPß or C/EBP in 3T3-L1 cells after exposure to the differentiating cocktail (COC). T47D cells (TCM) also suppressed the expression of aP2, a marker of differentiated adipocytes. C, on day 6, NCM did not change the expression patterns of C/EBPs and PPAR. Furthermore, the addition of an anti-TNF neutralizing antibody completely abolished the influence of TCM on C/EBPs and PPAR, indicating the essential role of TNF- in mediating the effects of TCM. Please note that Northern blots in A–C represent separate experiments, and exposure times of autoradiographs were different.

View larger version (29K): [in this window] [in a new window]   Fig. 3. Expression patterns of C/EBPs in mastectomy specimens from 10 patients with breast cancer. Immunoreactive proteins were scored in the three biopsies (intratumoral; fat, 1 cm to tumor; and fat, 2–4 cm to tumor; from each of the 10 mastectomy specimens). H-scoring was used in the following manner: 0, 0–5% fibroblasts are positive; 1, 6–25% fibroblasts are positive; 2, 26–50% fibroblasts are positive; 3, 51–75% fibroblasts are positive; and 4, 76–100% fibroblasts are positive. Immunoreactive C/EBP is not detected in the fibroblasts within the breast tumor but is readily detectable in the fibroblasts/adipocytes distant to the tumor. Immunoreactive C/EBPß and C/EBP are readily detectable in all of the three biopsy sites. , intratumoral; , adipose tissue (1 cm); , adipose tissue (2–4 cm). Bars, SE.

	DISCUSSION

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Peri- and intratumoral fibroblasts provide structural support to tumor tissue, and secretory products of fibroblasts may promote tumor growth. We herein demonstrated that malignant breast epithelial cells actively participate in the process of accumulation of stromal fibroblasts in and around the tumor tissue (i.e., desmoplastic reaction). Secretory products of cancer cells prevent the differentiation of fibroblasts to adipocytes and, in fact, may even reverse adipocyte differentiation. We also demonstrated that tumor-derived cytokines act on adjacent adipose stroma by down-regulating the expression of adipogenic factors such as the C/EBP and PPAR. This study also provides evidence that breast cancer cells (or their secretory products) do not induce proliferation of fibroblasts. Thus, inhibition of differentiation seems to be the major mechanism responsible for desmoplastic reaction.

We chose to study IL-11 and TNF- as the malignant epithelial cell-derived factors, because the potent antiadipogenic effects of these two cytokines have been well established (27, 28, 29) . In our hands, the combined effects of IL-11 and TNF- were sufficient to inhibit adipocyte differentiation completely. Most importantly, both cytokines are expressed in abundant levels in malignant epithelial cells. The effects of these cytokines are specific for malignant cells, because other cytokines or benign breast epithelial cells did not inhibit adipocyte differentiation.

Differentiation of fibroblastic cells to adipocytes appears to be primarily controlled by a cascade of adipogenic factors. C/EBPß and C/EPB appear to mediate the earlier phase of the differentiation program. PPAR, a nuclear hormone receptor, is expressed next in the differentiation process and becomes adipogenic after binding to its synthetic (BRL49653; Ref. 26 ) and natural (15-deoxy-^12,14-prostaglandin J₂) ligands (23) . PPAR binds to its response elements in the promoters of its target genes. To recognize a PPAR response element, PPAR must form a heterodimer with retinoid X receptor , a basic-leucine zipper transcription factor. On the other hand, C/EBP is not expressed until relatively late in the differentiation process. It binds to and transactivates the promoters of a number of adipocyte-specific genes. Thus, breast cancer cells seem to exert their inhibitory effect on relatively later stages of the differentiating process, i.e., inhibition of the expression of PPAR and C/EBP. This is consistent with the isolated effects of TNF-, which has been shown to inhibit the expression of PPAR and C/EBP in 3T3-L1 cells and fetal brown adipocytes (27 , 28) .

This report lays the groundwork for the mechanism of desmoplastic reaction as an epithelial-stromal interaction in the breast cancer. Further studies are required to identify other key molecules in the cancer-mediated inhibition of adipocyte differentiation. Two candidate substances are CHOP, a transcription factor that acts as a negative dominant regulator of adipocyte differentiation, and Pref-1, which is a transmembrane protein with epidermal growth factor-like motifs and another negative regulator of adipocyte differentiation (30) . The determination of the roles of these candidate substances will further increase our understanding of the epithelial-stromal interactions in the breast cancer. Finally, we recently showed that cancer cell-induced up-regulation of C/EBPß mediates aromatase overexpression in adipose fibroblasts (31).

	ACKNOWLEDGMENTS

 
We are thankful for the expert editorial assistance of Denise Middleton and Dee Alexander.

	FOOTNOTES

 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ Supported by National Cancer Institute Grant CA67167 and United States Army Medical Research and Materiel Command Grant DAMD17-97-1-7025 (to S. E. B.) and an American Association of Obstetricians and Gynecologists Foundation Fellowship Award (to K. M. Z.).

² These authors contributed to this work equally.

³ To whom requests for reprints should be addressed, at Departments of Obstetrics and Gynecology and Molecular Genetics, University of Illinois at Chicago, 820 South Wood Street, M/C 808, Chicago, IL 60612. Phone: (312) 996-8197; Fax: (312) 996-4238; E-mail: sbulun{at}uic.edu

⁴ The abbreviations used are: P450arom, aromatase P450; IL, interleukin; C/EBP, CCAAT/enhancer binding protein; PPAR, peroxisome proliferator-activated receptor; TNF, tumor necrosis factor; DEX, dexamethasone; MIX, 1-methyl-3-isobutyl-xanthine; TCM, T47D cell conditioned medium; NCM, normal mammary epithelial cell conditioned medium.

⁵ J. E. Nichols, S. E. Bulun, and E. R. Simpson, unpublished observations.

Received 11/29/99. Accepted 12/28/00.

	REFERENCES

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 

1. Haagensen C. D. Diseases of the Breast Ed. 3 635-641, W. B. Saunders Co. Philadelphia 1986.
2. Dickson R. B., Lippman M. E. Growth factors in breast cancer. Endocr. Rev., 16: 559-589, 1995.[Medline]
3. Haslam S. Z. Stromal-epithelial interactions in normal and neoplastic mammary gland Lippman M. E. Dickson R. B. eds. . Regulatory Mechanisms in Breast Cancer, : 401-420, Kluwer Academic Publishers Boston 1991.
4. Bulun S. E., Simpson E. R. Breast cancer and expression of aromatase in breast adipose tissue. Trends Endocrinol. Metab., 5: 113-120, 1994.
5. Hauner H., Entenmann G., Wabitsch M., Gaillard D., Ailhaud G., Negrel R., Pfeiffer E. F. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J. Clin. Invest., 84: 1663-1670, 1989.
6. Adams M., Prins J., Holder J., Sanders L., Smith S., O’Rahilly S., Chatterjee V. K. K. Thiazolidinediones promote human pre-adipocyte differentiation and activate hPPAR. Endocr. Soc., 78: 137 1996.
7. Bulun S. E., Prince T. M., Mahendroo M. S., Aitken J., Simpson E. R. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J. Clin. Endocrinol. Metab., 77: 1622-1628, 1993.[Abstract]
8. Ackerman G. E., Smith M. E., Mendelson C. R., MacDonald P. C., Simpson E. R. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J. Clin. Endocrinol. Metab., 53: 412-417, 1981.[Abstract]
9. Price T., Aitken J., Head J., Mahendroo M. S., Means G. D., Simpson E. R. Determination of aromatase cytochrome P450 messenger RNA in human breast tissues by competitive polymerase chain reaction (PCR) amplification. J. Clin. Endocrinol. Metab., 74: 1247-1252, 1992.[Abstract]
10. Bulun S. E., Sharda G., Rink J., Sharma S., Simpson E. R. Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast. J. Clin. Endocrinol. Metab., 81: 1273-1277, 1996.[Abstract]
11. Nichols J. E., Bulun S. E., Simpson E. R. Effects of conditioned medium from different cultured cell types on aromatase expression in adipose stromal cells. J. Soc. Gynecol. Investig., 2: 45-50, 1995.[Medline]
12. Crichton M. B., Nichols J. E., Zhao Y., Bulun S. E., Simpson E. R. Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Mol. Cell. Endocrinol., 118: 215-220, 1996.[Medline]
13. Zhao Y., Nichols J. E., Bulun S. E., Mendelson C. R., Simpson E. R. Aromatase P450 gene expression in human adipose tissue: role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J. Biol. Chem., 270: 16449-16457, 1995.[Abstract/Free Full Text]
14. Reed M. J., Topping L., Coldham N. G., Purohit A., Ghilchik M. W., James V. H. T. Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors. J. Steroid Biochem. Mol. Biol., 44: 589-596, 1993.[Medline]
15. Smith P. J., Wise L. S., Berkowitz R., Wan C., Rubin C. S. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3–L1 adipocytes. J. Biol. Chem., 263: 9402-9408, 1988.[Abstract/Free Full Text]
16. Boney C. M., Smith R. M., Gruppuso P. A. Modulation of insulin-like growth factor I mitogenic signaling in 3T3–L1 preadipocyte differentiation. Endocrinology, 139: 1638-1644, 1998.[Abstract/Free Full Text]
17. Adachi H., Kurachi H., Homma H., Adachi K., Imai T., Morishige K., Matsuzawa Y., Miyake A. Epidermal growth factor promotes adipogenesis of 3T3–L1 cell in vitro. Endocrinology, 135: 1824-1830, 1994.[Abstract]
18. Schmidt W., Poll-Jordan G., Loffler G. Adipose conversion of 3T3–L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP. J. Biol. Chem., 265: 15489-15495, 1990.[Abstract/Free Full Text]
19. Wu Z., Xie Y., Bucher N. L. R., Farmer S. R. Conditional ectopic expression of C/EBPß in NIH-3T3 cells induces PPAR and stimulates adipogenesis. Genes Dev., 9: 2350-2363, 1995.[Abstract/Free Full Text]
20. Cao Z., Umek R. M., McKnight S. L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3–L1 cells. Genes Dev., 5: 1538-1552, 1991.[Abstract/Free Full Text]
21. Tontonoz P., Hu E., Graves R. A., Budavari A. I., Spiegelman B. M. PPAR2: tissue-specific regulator of an adipocyte enhancer. Genes Dev., 8: 1224-1234, 1994.[Abstract/Free Full Text]
22. Hu E., Tontonoz P., Spiegelman B. M. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR and C/EBP. Proc. Natl. Acad. Sci. USA, 92: 9856-9860, 1995.[Abstract/Free Full Text]
23. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M. 15-Deoxy-^{12, 14}-prostaglandin J₂ is a ligand for the adipocyte determination factor PPAR. Cell, 83: 803-812, 1995.[Medline]
24. Tontonoz P., Hu E., Spiegelman B. M. Stimulation of adipogenesis in fibroblasts by PPAR2, a lipid-activated transcription factor. Cell, 79: 1147-1156, 1994.[Medline]
25. Zhang B., Berger J., Szalkowski D., White-Carrington S., Moller D. E. Negative regulation of PPAR gene expression underlies the anti-adipogenic effects of TNF. Proc. 10th Int. Congress Endocrinol., 10: 141 1996.
26. Lehmann J. M., Moore L. B., Smith-Oliver T. Z., Wilkison W. O., Willson T. M., Kliewer S. A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor (PPAR). J. Biol. Chem., 270: 12953-12956, 1995.[Abstract/Free Full Text]
27. Zhang B., Berger J., Hu E., Szalkowski D., White-Carrington S., Spiegelman B. M., Moller D. E. Negative regulation of peroxisome proliferator-activated receptor- gene expression contributes to the antiadipogenic effects of tumor necrosis factor-. Mol. Endocrinol., 10: 1457-1466, 1996.[Abstract]
28. Valverde A. M., Teruel T., Navarro P., Benito M., Lorenzo M. Tumor necrosis factor- causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes. Endocrinology, 139: 1229-1238, 1998.[Abstract/Free Full Text]
29. Kawashima I., Ohsumi J., Mita-Honjo K., Shimoda-Takano K., Ishikawa H, Sakakibara S., Miyadai K., Takiguchi Y. Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin-11. FEBS Lett., 283: 199-202, 1991.[Medline]
30. Smas C. M., Sul H. S. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell, 73: 725-734, 1993.[Medline]
31. Zhou J., Gurates B., Yang S., Sebastian S., Bulun S. E. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein ß. Cancer Res., 61: 2328-2334, 2001.[Abstract/Free Full Text]

This article has been cited by other articles:

				I. Kijima, J. Ye, C. Glackin, and S. Chen CCAAT/Enhancer Binding Protein {delta} Up-regulates Aromatase Promoters I.3/II in Breast Cancer Epithelial Cells Cancer Res., June 1, 2008; 68(11): 4455 - 4464. [Abstract] [Full Text] [PDF]

				H. Ishikawa, V. Fencki, E. E. Marsh, P. Yin, D. Chen, Y.-H. Cheng, S. Reisterd, Z. Lin, and S. E. Bulun CCAAT/Enhancer Binding Protein {beta} Regulates Aromatase Expression via Multiple and Novel Cis-Regulatory Sequences in Uterine Leiomyoma J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 981 - 991. [Abstract] [Full Text] [PDF]

				D. Chen, S. Reierstad, Z. Lin, M. Lu, C. Brooks, N. Li, J. Innes, and S. E. Bulun Prostaglandin E2 Induces Breast Cancer Related Aromatase Promoters via Activation of p38 and c-Jun NH2-Terminal Kinase in Adipose Fibroblasts Cancer Res., September 15, 2007; 67(18): 8914 - 8922. [Abstract] [Full Text] [PDF]

				L. Vona-Davis and D. P Rose Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression Endocr. Relat. Cancer, June 1, 2007; 14(2): 189 - 206. [Abstract] [Full Text] [PDF]

				D. Falconi, K. Oizumi, and J. E. Aubin Leukemia Inhibitory Factor Influences the Fate Choice of Mesenchymal Progenitor Cells Stem Cells, February 1, 2007; 25(2): 305 - 312. [Abstract] [Full Text] [PDF]

				S. Ghosh, Y. Lu, A. Katz, Y. Hu, and R. Li Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E246 - E252. [Abstract] [Full Text] [PDF]

				S. Deb, J. Zhou, S. A. Amin, A. G. Imir, M. B. Yilmaz, Z. Lin, and S. E. Bulun A Novel Role of Sodium Butyrate in the Regulation of Cancer-associated Aromatase Promoters I.3 and II by Disrupting a Transcriptional Complex in Breast Adipose Fibroblasts J. Biol. Chem., February 3, 2006; 281(5): 2585 - 2597. [Abstract] [Full Text] [PDF]

				K. L. Andarawewa, E. R. Motrescu, M.-P. Chenard, A. Gansmuller, I. Stoll, C. Tomasetto, and M.-C. Rio Stromelysin-3 Is a Potent Negative Regulator of Adipogenesis Participating to Cancer Cell-Adipocyte Interaction/Crosstalk at the Tumor Invasive Front Cancer Res., December 1, 2005; 65(23): 10862 - 10871. [Abstract] [Full Text] [PDF]

				S. E. Bulun, Z. Lin, G. Imir, S. Amin, M. Demura, B. Yilmaz, R. Martin, H. Utsunomiya, S. Thung, B. Gurates, et al. Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment Pharmacol. Rev., September 1, 2005; 57(3): 359 - 383. [Abstract] [Full Text] [PDF]

				P.-L. Yao, Y.-C. Lin, C.-H. Wang, Y.-C. Huang, W.-Y. Liao, S.-S. Wang, J. J. W. Chen, and P.-C. Yang Autocrine and Paracrine Regulation of Interleukin-8 Expression in Lung Cancer Cells Am. J. Respir. Cell Mol. Biol., June 1, 2005; 32(6): 540 - 547. [Abstract] [Full Text] [PDF]

				S. Deb, S. Amin, A. G. Imir, M. B. Yilmaz, T. Suzuki, H. Sasano, and S. E. Bulun Estrogen Regulates Expression of Tumor Necrosis Factor Receptors in Breast Adipose Fibroblasts J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4018 - 4024. [Abstract] [Full Text] [PDF]

				W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196. [Abstract] [Full Text] [PDF]

				S. Yamasaki, T. Nakashima, A. Kawakami, T. Miyashita, F. Tanaka, H. Ida, K. Migita, T. Origuchi, and K. Eguchi Cytokines regulate fibroblast-like synovial cell differentiation to adipocyte-like cells Rheumatology, April 1, 2004; 43(4): 448 - 452. [Abstract] [Full Text] [PDF]

				H. Enomoto, T. Furuichi, A. Zanma, K. Yamana, C. Yoshida, S. Sumitani, H. Yamamoto, M. Enomoto-Iwamoto, M. Iwamoto, and T. Komori Runx2 deficiency in chondrocytes causes adipogenic changes in vitro J. Cell Sci., January 22, 2004; 117(3): 417 - 425. [Abstract] [Full Text] [PDF]

				K.-i. Komine, T. Kuroishi, Y. Komine, K. Watanabe, J. Kobayashi, T. Yamaguchi, S.-i. Kamata, and K. Kumagai Induction of Nitric Oxide Production Mediated by Tumor Necrosis Factor Alpha on Staphylococcal Enterotoxin C-Stimulated Bovine Mammary Gland Cells Clin. Vaccine Immunol., January 1, 2004; 11(1): 203 - 210. [Abstract] [Full Text] [PDF]

				H. Lapillonne, M. Konopleva, T. Tsao, D. Gold, T. McQueen, R. L. Sutherland, T. Madden, and M. Andreeff Activation of Peroxisome Proliferator-activated Receptor {gamma} by a Novel Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Induces Growth Arrest and Apoptosis in Breast Cancer Cells Cancer Res., September 15, 2003; 63(18): 5926 - 5939. [Abstract] [Full Text] [PDF]

				M. Zinger, M. McFarland, and N. Ben-Jonathan Prolactin Expression and Secretion by Human Breast Glandular and Adipose Tissue Explants J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 689 - 696. [Abstract] [Full Text] [PDF]

				J. Zhou, B. Gurates, S. Yang, S. Sebastian, and S. E. Bulun Malignant Breast Epithelial Cells Stimulate Aromatase Expression via Promoter II in Human Adipose Fibroblasts: An Epithelial-Stromal Interaction in Breast Tumors Mediated by CCAAT/Enhancer Binding Protein {beta} Cancer Res., March 1, 2001; 61(5): 2328 - 2334. [Abstract] [Full Text]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles